Literature DB >> 24353097

Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia.

Yuan Xiao1, Su Lui2, Wei Deng3, Li Yao1, Wenjing Zhang1, Shiguang Li1, Min Wu1, Teng Xie4, Yong He4, Xiaoqi Huang1, Junmei Hu3, Feng Bi5, Tao Li3, Qiyong Gong1.   

Abstract

Although previous studies have reported deficits in the gray matter volume of schizophrenic patients, it remains unclear whether these deficits occur at the onset of the disease, before treatment, and whether they are progressive over the duration of untreated disease. Furthermore, the gray matter volume represents the combinations of cortical thickness and surface area; these features are believed to be influenced by different genetic factors. However, cortical thickness and surface area in antipsychotic-naive first-episode schizophrenic patients have seldom been investigated. Here, the cortical thicknesses and surface areas of 128 antipsychotic-naive first-episode schizophrenic patients were compared with 128 healthy controls. The patients exhibited significantly lower cortical thickness, primarily in the bilateral prefrontal and parietal cortex, and increased thickness in the bilateral anterior temporal lobes, left medial orbitofrontal cortex, and left cuneus. Furthermore, decreased cortical thickness was related to positive schizophrenia symptoms but not to the severity of negative symptoms and the untreated disease duration. No significant difference of surface area was observed between the 2 groups. Thus, without the confounding factors of medication and illness progression, this study provides further evidence to support anatomical deficits in the prefrontal and parietal cortex early in course of the illness. The increased thicknesses of the bilateral anterior temporal lobes may represent a compensatory factor or may be an early-course neuronal pathology caused by preapoptotic osmotic changes or hypertrophy. Furthermore, these anatomical deficits are crucial to the pathogenesis of positive symptoms and relatively stable instead of progressing during the early stages of the disease.
© The Author 2013. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MRI; antipsychotic-naive; cortical thickness; first-episode; schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 24353097      PMCID: PMC4266280          DOI: 10.1093/schbul/sbt177

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  74 in total

1.  Cortical thickness reduction in individuals at ultra-high-risk for psychosis.

Authors:  Wi Hoon Jung; June Sic Kim; Joon Hwan Jang; Jung-Seok Choi; Myung Hun Jung; Ji-Young Park; Ji Yeon Han; Chi-Hoon Choi; Do-Hyung Kang; Chun Kee Chung; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2009-12-21       Impact factor: 9.306

2.  Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.

Authors:  M R Williams; R Chaudhry; S Perera; R K B Pearce; S R Hirsch; O Ansorge; M Thom; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-19       Impact factor: 5.270

3.  Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.

Authors:  Vina M Goghari; Geoffrey N Smith; William G Honer; Lili C Kopala; Allen E Thornton; Wayne Su; G William Macewan; Donna J Lang
Journal:  Schizophr Res       Date:  2013-07-04       Impact factor: 4.939

4.  Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis.

Authors:  Emre Bora; Alex Fornito; Joaquim Radua; Mark Walterfang; Marc Seal; Stephen J Wood; Murat Yücel; Dennis Velakoulis; Christos Pantelis
Journal:  Schizophr Res       Date:  2011-04       Impact factor: 4.939

5.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02

6.  Changes in cortical thickness during the course of illness in schizophrenia.

Authors:  Neeltje E M van Haren; Hugo G Schnack; Wiepke Cahn; Martijn P van den Heuvel; Claude Lepage; Louis Collins; Alan C Evans; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2011-09

7.  Neuroimaging evidence for the deficit subtype of schizophrenia.

Authors:  Aristotle N Voineskos; George Foussias; Jason Lerch; Daniel Felsky; Gary Remington; Tarek K Rajji; Nancy Lobaugh; Bruce G Pollock; Benoit H Mulsant
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

8.  Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.

Authors:  Anthony C Vernon; Sridhar Natesan; Mike Modo; Shitij Kapur
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382

Review 9.  The myth of schizophrenia as a progressive brain disease.

Authors:  Robert B Zipursky; Thomas J Reilly; Robin M Murray
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  33 in total

1.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

2.  Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.

Authors:  Tianhao Zhang; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2014-09-26       Impact factor: 9.306

3.  A Systematic Characterization of Structural Brain Changes in Schizophrenia.

Authors:  Wasana Ediri Arachchi; Yanmin Peng; Xi Zhang; Wen Qin; Chuanjun Zhuo; Chunshui Yu; Meng Liang
Journal:  Neurosci Bull       Date:  2020-06-03       Impact factor: 5.203

4.  Brain Structural Correlates of Metacognition in First-Episode Psychosis.

Authors:  Erkan Alkan; Geoff Davies; Kathryn Greenwood; Simon L H Evans
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

5.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET.

Authors:  Fernando Caravaggio; Jun Ku Chung; Eric Plitman; Isabelle Boileau; Philip Gerretsen; Julia Kim; Yusuke Iwata; Raihaan Patel; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2017-07-28       Impact factor: 5.038

6.  The neurobiology of transition to psychosis: clearing the cache.

Authors:  Lena Palaniyappan; Tushar Das; Kara Dempster
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

7.  Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders.

Authors:  Jaya L Padmanabhan; Neeraj Tandon; Chiara S Haller; Ian T Mathew; Shaun M Eack; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2014-06-06       Impact factor: 9.306

Review 8.  Psychoradiology: The Frontier of Neuroimaging in Psychiatry.

Authors:  Su Lui; Xiaohong Joe Zhou; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2016-11       Impact factor: 11.105

9.  GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia.

Authors:  Chengcheng Zhang; Peiyan Ni; Yikang Liu; Yang Tian; Jinxue Wei; Bo Xiang; Liansheng Zhao; Xiaojing Li; Xiaohong Ma; Wei Deng; Wanjun Guo; Rongjun Ni; Yamin Zhang; Qiang Wang; Hailiang Huang; Nanyin Zhang; Tao Li
Journal:  Neurosci Bull       Date:  2019-08-06       Impact factor: 5.203

10.  Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.

Authors:  E Walton; D P Hibar; T G M van Erp; S G Potkin; R Roiz-Santiañez; B Crespo-Facorro; P Suarez-Pinilla; N E M van Haren; S M C de Zwarte; R S Kahn; W Cahn; N T Doan; K N Jørgensen; T P Gurholt; I Agartz; O A Andreassen; L T Westlye; I Melle; A O Berg; L Morch-Johnsen; A Færden; L Flyckt; H Fatouros-Bergman; E G Jönsson; R Hashimoto; H Yamamori; M Fukunaga; N Jahanshad; P De Rossi; F Piras; N Banaj; G Spalletta; R E Gur; R C Gur; D H Wolf; T D Satterthwaite; L M Beard; I E Sommer; S Koops; O Gruber; A Richter; B Krämer; S Kelly; G Donohoe; C McDonald; D M Cannon; A Corvin; M Gill; A Di Giorgio; A Bertolino; S Lawrie; T Nickson; H C Whalley; E Neilson; V D Calhoun; P M Thompson; J A Turner; S Ehrlich
Journal:  Psychol Med       Date:  2017-05-26       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.